CO5200850A1 - PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION - Google Patents
PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATIONInfo
- Publication number
- CO5200850A1 CO5200850A1 CO00057176A CO00057176A CO5200850A1 CO 5200850 A1 CO5200850 A1 CO 5200850A1 CO 00057176 A CO00057176 A CO 00057176A CO 00057176 A CO00057176 A CO 00057176A CO 5200850 A1 CO5200850 A1 CO 5200850A1
- Authority
- CO
- Colombia
- Prior art keywords
- influenza
- treatment
- profilaxis
- flu
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000011282 treatment Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 206010022000 influenza Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 abstract 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 abstract 1
- 206010022004 Influenza like illness Diseases 0.000 abstract 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 201000009240 nasopharyngitis Diseases 0.000 abstract 1
- 239000000280 phytoalexin Substances 0.000 abstract 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a una composición que incluye una fitoalexina estilbénica usada en un método para la profilaxis y tratamiento de síntomas del resfriado y similares a la influenza que comprende la administración de dicha composición a un sujeto, la cual tiene la estructura: <EMI FILE="00057176_1" ID="1" IMF=JPEG > en donde R1, R2, R3, R4, R5 y R6 independientemente se seleccionan de hidrógeno e hidroxi; y sales o ésteres medicinalmente aceptables de éstos.The present invention relates to a composition that includes a stylogenic phytoalexin used in a method for the prophylaxis and treatment of cold and influenza-like symptoms comprising the administration of said composition to a subject, which has the structure: <EMI FILE = "00057176_1" ID = "1" MFI = JPEG> where R1, R2, R3, R4, R5 and R6 are independently selected from hydrogen and hydroxy; and medicinally acceptable salts or esters thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36494499A | 1999-07-30 | 1999-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5200850A1 true CO5200850A1 (en) | 2002-09-27 |
Family
ID=23436803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO00057176A CO5200850A1 (en) | 1999-07-30 | 2000-07-31 | PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1221949A2 (en) |
| JP (1) | JP2003505500A (en) |
| CN (1) | CN1377262A (en) |
| AU (1) | AU6240200A (en) |
| CA (1) | CA2379703A1 (en) |
| CO (1) | CO5200850A1 (en) |
| HK (1) | HK1049104A1 (en) |
| PE (1) | PE20010540A1 (en) |
| TR (1) | TR200200246T2 (en) |
| WO (1) | WO2001008671A2 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6878751B1 (en) | 2000-10-19 | 2005-04-12 | Imperial College Of Science Technology And Medicine | Administration of resveratrol to treat inflammatory respiratory disorders |
| ITRM20020562A1 (en) * | 2002-11-06 | 2004-05-07 | Sigma Tau Ind Farmaceuti | USE OF THE RESVERATROL FOR THE PREPARATION OF A USEFUL DRUG FOR THE TREATMENT OF INFLUENCE VIRUS INFECTIONS. |
| EP1845957B1 (en) * | 2005-02-04 | 2010-12-22 | Peter Heger | Method for producing a drug extract that contains hydroxystilbenes |
| DE602006013787D1 (en) * | 2006-03-28 | 2010-06-02 | Epitech Group Srl | A pharmaceutical composition for the treatment of pathologies caused by the general immune response |
| CN100453071C (en) * | 2006-11-03 | 2009-01-21 | 李万忠 | Oral resveratrol multi-phase liposome and preparation method thereof |
| JPWO2008136173A1 (en) * | 2007-04-20 | 2010-07-29 | 国立大学法人お茶の水女子大学 | Adipocyte differentiation inhibitor comprising a stilbene derivative as an active ingredient |
| US20090175803A1 (en) | 2008-01-08 | 2009-07-09 | David Rubin | Method and compositions for administering resveratrol and pterostilbene |
| FR2933871B1 (en) * | 2008-07-18 | 2012-12-14 | Yvery | FORMULATION FOR IMPROVING THE BIOAVAILABILITY OF A HYDROPHOBIC MOLECULE |
| JP5926200B2 (en) * | 2010-03-12 | 2016-05-25 | シナーゲン リサーチ リミティッド | Treatment of influenza-like diseases |
| JP5848042B2 (en) | 2011-06-29 | 2016-01-27 | 株式会社ロッテ | Eye fatigue inhibiting composition and food and drink containing the same |
| US20140303260A1 (en) * | 2011-10-19 | 2014-10-09 | Nad Life Pty Ltd | Pharmaceutical compositions of resveratrol |
| CN106581028A (en) * | 2016-11-30 | 2017-04-26 | 南宁市浩特竹鼠养殖场 | Western medicine for curing cold of bamboo rat and preparation method of western medicine |
| WO2021204520A1 (en) * | 2020-04-10 | 2021-10-14 | Galenus G.H. Ag | Composition comprising resveratrol |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0753359A (en) * | 1993-06-11 | 1995-02-28 | Kao Corp | Lipoxygenase inhibitor |
| FR2778337B1 (en) * | 1998-05-05 | 2001-08-31 | Inst Nat Sante Rech Med | ARYLHYDROCARBON RECEPTOR LIGAND ANTAGONISTS |
| AU4084599A (en) * | 1998-05-18 | 1999-12-06 | Oklahoma Medical Research Foundation | Resveratrol inhibition of myeloperoxidase |
| US6197834B1 (en) * | 1998-09-01 | 2001-03-06 | Northeastern Ohio Universities College Of Medicine | Method of inhibiting formation of infectious herpes virus particles |
| CA2339049C (en) * | 1998-09-08 | 2010-02-23 | Cornell Research Foundation, Inc. | Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors |
-
2000
- 2000-07-26 PE PE2000000750A patent/PE20010540A1/en not_active Application Discontinuation
- 2000-07-28 JP JP2001513401A patent/JP2003505500A/en not_active Withdrawn
- 2000-07-28 AU AU62402/00A patent/AU6240200A/en not_active Abandoned
- 2000-07-28 TR TR2002/00246T patent/TR200200246T2/en unknown
- 2000-07-28 EP EP00948987A patent/EP1221949A2/en not_active Withdrawn
- 2000-07-28 CA CA002379703A patent/CA2379703A1/en not_active Abandoned
- 2000-07-28 HK HK02109229.2A patent/HK1049104A1/en unknown
- 2000-07-28 CN CN00810896A patent/CN1377262A/en active Pending
- 2000-07-28 WO PCT/US2000/020658 patent/WO2001008671A2/en not_active Application Discontinuation
- 2000-07-31 CO CO00057176A patent/CO5200850A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1221949A2 (en) | 2002-07-17 |
| HK1049104A1 (en) | 2003-05-02 |
| WO2001008671A2 (en) | 2001-02-08 |
| CA2379703A1 (en) | 2001-02-08 |
| JP2003505500A (en) | 2003-02-12 |
| TR200200246T2 (en) | 2002-09-23 |
| WO2001008671A3 (en) | 2002-05-02 |
| PE20010540A1 (en) | 2001-05-15 |
| AU6240200A (en) | 2001-02-19 |
| CN1377262A (en) | 2002-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2524458T3 (en) | DNase for the treatment of male subfertility | |
| AR026610A1 (en) | A PIRROLIDINACETAMIDE DERIVATIVE ONLY OR IN COMBINATION FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | |
| DE60143393D1 (en) | MODIFIED FORMS PHARMACEUTICALLY ACTIVE AGENTS AND USES THEREOF | |
| CO5200850A1 (en) | PHARMACEUTICAL COMPOSITION FOR PROFILAXIS AND TREATMENT OF SYMPTOMS ASSOCIATED WITH THE FLU, INFLUENZA AND SIMILAR DISEASES AND PROCEDURE FOR APPLICATION | |
| CO5160320A1 (en) | METHODS AND COMPOSITIONS FOR THE PREVENTION OF TOLERANCE TO MEDICINES DAS. | |
| CL2008003938A1 (en) | Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00). | |
| JP2005532372A5 (en) | ||
| BR0008059A (en) | Compositions of valdecoxib | |
| UY28041A1 (en) | LOW DOSE METHODS FOR THE TREATMENT OF DISORDERS IN WHICH TNFA'S ACTIVITY IS HARMFUL. | |
| DE60223254D1 (en) | DELAYED FORCULATING FORMULATIONS OF OXYMORPHONE | |
| AR034746A1 (en) | COMBINATIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | |
| BR0114799A (en) | Cyanophenoxy carboxylic acid compounds and compositions for releasing active agents | |
| AR034900A1 (en) | USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT | |
| BR9509019A (en) | Process for manufacturing pharmaceutical dosage units and tablet free of organic solvents | |
| EA200201276A1 (en) | ARYLMETYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS | |
| DE60322075D1 (en) | PPAR ALPHA SELECTIVE COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER LIPID DISORDERS | |
| ES2170143T3 (en) | COMPOSITIONS THAT INCLUDE HALOFANTRINE IN A SPECIAL FORM. | |
| ATE249835T1 (en) | IMMUNOREGULATOR | |
| AR032614A1 (en) | CONTROLLED ORAL ADMINISTRATION SYSTEM FOR DAILY INTAKE OF CIPROFLOXACINE | |
| AR039162A1 (en) | VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION | |
| AR018376A1 (en) | PHARMACEUTICAL COMPOSITIONS THAT CAN BE DISPERSED IN A SPONTANEOUS WAY AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| BRPI0412506A (en) | autologous cells that induce self-tolerance of monocytically originated and their use in pharmaceutical preparations | |
| ATE261732T1 (en) | PHARMACEUTICAL COMPOSITION COMPRISING EUCALYPTUS AND ORANGE OIL | |
| CO5261573A1 (en) | DERIVATIVES OF BENZOXA AND BEZOTIAZOL, COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THEM AND PROCESS FOR THE PREPARATION OF THE MENTIONED COMPOSITION | |
| DK1227826T3 (en) | Compositions comprising an extract of Perna canaliculus, methylsulfonylmethane and glucosamide and the use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |